-
161
Genome sequencing enhances the diagnostic yield and expands the genetic landscape of male breast cancer
Published 2025-01-01Get full text
Article -
162
-
163
NLRP12-Associated Autoinflammatory Disease in Chinese Adult Patients: A Single-Centre Study
Published 2024-10-01Get full text
Article -
164
Genetic Polymorphisms: A Novel Perspective on Acute Pancreatitis
Published 2017-01-01Get full text
Article -
165
Adiponectin and Leptin Metabolic Biomarkers in Chinese Children and Adolescents
Published 2010-01-01Get full text
Article -
166
Progress in the Study of Polymyxin Heteroresistance Molecular Mechanisms
Published 2024-11-01Get full text
Article -
167
-
168
Chinese Guidelines for the Clinical Management of Obesity (2024 Edition)
Published 2024-11-01Get full text
Article -
169
Interpretation on the 2024 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis
Published 2024-12-01Get full text
Article -
170
Atypical Hemolytic Uremic Syndrome with Eosinophilia and Purtscher-like Retinopathy: A Case Report
Published 2024-12-01Get full text
Article -
171
Vincristine Regulates C/EBP-β/TGF-β1 to Promote A1 Astrocyte Polarization and Induce Neuropathic Pain
Published 2025-02-01“…Yunfu Chen,1,* Guangling Tang,1,* Jun Lu,1,* Sijie Tang,1 Xinglong Xiong,1 Chao Chen,1 Lijian Pei,2 Jing Shi1 1Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guizhou, People’s Republic of China; 2Department of Anesthesiology, Peking Union Medical College Hospital, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jing Shi, Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China, Tel +86-18685034016, Email shijing81@gmc.edu.cn Lijian Pei, Department of Anesthesiology, Peking Union Medical College Hospital, Beijing, People’s Republic of China, Email hazelbeijing@vip.163.comBackground: The neuropathic pain side induced by Vincristine severely limit its clinical application. …”
Get full text
Article -
172
Impact of Food Physical Properties on Oral Drug Absorption: A Comprehensive Review
Published 2025-01-01“…Ziyang Wang,1 Wen Xu,2 Dan Liu,3 Xiuqi Li,1 Shupeng Liu,1 Xiaofei Wu,1 Hongyun Wang1 1Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 2CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd, Shijiazhuang, People’s Republic of China; 3College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of ChinaCorrespondence: Hongyun Wang, Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China, Tel +8610-69154637, Email wanghy@pumch.cnAbstract: Food-Drug Interaction (FDI) refers to the phenomenon where food affects the pharmacokinetic or pharmacodynamic characteristics of a drug, significantly altering the drug’s absorption rate or absorption extent. …”
Get full text
Article -
173
Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy
Published 2025-01-01Get full text
Article -
174
Stakeholder Preference Assessment in Implementation Research: Application of Best-worst Scaling
Published 2024-12-01Get full text
Article -
175
Research Progress on the Correlation Between Microecological Flora and Endometriosis
Published 2024-05-01Get full text
Article -
176
Interpretation of Updates to the Modern Diagnosis of GERD: Lyon Consensus 2.0
Published 2024-12-01Get full text
Article -
177
-
178
Advanced 3D bioprinted liver models with human-induced hepatocytes for personalized toxicity screening
Published 2025-01-01Get full text
Article -
179
Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Ph...
Published 2025-02-01“…Hao Su,1,* Xiao Shang,1,* Hongruo Liu,2 Yutong Wang,1 Yang Yu,3 Yanhua Xu,4 Kui Jiang,2,* Fengzhi Feng1,* 1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China; 2Department of Medical Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 3Department of Obstetrics and Gynecology, Xing’an League People’s Hospital, Xing’an League, Inner Mongolia, People’s Republic of China; 4Department of Obstetrics and Gynecology, Jinan Maternity and Child Health Care Hospital, Jinan, Shandong, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fengzhi Feng, Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuai Fu Yuan, Dong Cheng District, Beijing, 100730, People’s Republic of China, Email fengfz1969@sina.com Kui Jiang, Department of Medical Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116023, People’s Republic of China, Email jk0411@163.comPurpose: Therapeutic options for patients with platinum-resistant ovarian cancer (PROC) remain a major unmet need. …”
Get full text
Article -
180
Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
Published 2025-01-01Get full text
Article